Clinical trial
The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By…
NCT00045981 · Synvista Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00045981 |
|---|---|
| Title | The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity) |
| Official title | Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SAPPHIRE Study |
| Lead sponsor | Synvista Therapeutics, Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | ALT-711 |
| Enrollment | 450 |
| Start date | Oct 1, 2001 |
| Primary completion | May 1, 2003 |
| Completion | Aug 1, 2006 |
| First posted | Sep 19, 2002 |
| Last update posted | Mar 26, 2010 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: